CAMELOT FANTASIES

Tranzbyte and ATTBF Sign Letters of Intent Creating Strategic Production, Sales, and Distribution Partnership

.

Marketwired
 Tranzbyte Corporation
March 21, 2014 10:00 AM


     
TEMPE, AZ--(Marketwired - Mar 21, 2014) -  Tranzbyte Corporation (OTC Pink: ERBB)(PINKSHEETS: ERBB) (http://www.bloomberg.com/quote/ERBB:US) announced today that it has signed a Letter of Intent to form a strategic partnership with Abattis (OTC Pink: ATTBF)(PINKSHEETS: ATTBF) (CSE: ATT) (http://www.bloomberg.com/quote/ATTBF:US) to sell, market or otherwise license one another's products in their respective regions. Once the arrangement is completed, Tranzbyte will have access to Abattis's expanding suite of bio-ceutical grow products found in the Biocube Green Grow Systems for cultivation (LED's, Nutrients - Natures Juice). In addition Abattis owns proprietary flash freeze extraction technology, which produces high-grade cannabis and other botanical extracts. Conversely, Abattis will have the Canadian rights to distribute ZaZZZ™ and will pair Tranzbyte's Jurassic O2 water systems with its Biocube Green Grow Systems sales efforts in the US.





 "When one looks at the obvious NAFTA synergy, this relationship makes all the sense in the world. Abattis is a powerhouse in Canada; we are stronger in the US. From cross-promotion to extended sales and marketing, the opportunities that will be created with the two companies working together will be nothing short of phenomenal," says Stephen Shearin, Tranzbyte COO.

According to David Gwyther, Tranzbyte's president, "I am very impressed with Abattis's commitment to the research, development, and marketing capability they've shown involving their proprietary, natural health and wellness solutions which address chronic illnesses through targeted nutritional support and, thus, fit perfectly into Tranzbyte's future plans. Working together leverages our collective visions for this vast and expanding marketplace."

In addition, Abattis owns flash-freeze extraction technology that produces the highest grade flower extract which is in high demand today. Conventional extraction methods require heat and solvents which can increase liabilities for dispensaries who extract on-site. The Northern Vine cold press extraction owned by Abattis is exactly what the industry needs to fulfill patient orders in a clean safe manner. "This offers dispensaries and growers a complete end-to-end solution of cutting-edge grow technologies and plant analysis," comments Mike Withrow, CEO of Abattis. "In addition, with the rights to the ZaZZZ™ automated vending opportunity as the regulatory climate evolves in Canada, we open up a lot of growth potential. Merging the efforts of the leading companies in each country should build real shareholder value for each company."

In other news, the medical and social marijuana division, formally, Altitude Organix, is changing to American Green™. The company has purchased both domain and trademark rights to the name. Its new logo (below) has been designed to evoke a time before prohibition, when hard working people had more leeway in their choice of medicine and their pursuit of happiness. American Green™ is carrying on the American Dream.

Tranzbyte encourages all folks wishing to follow the progress of Tranzbyte, Altitude Organix, and its other subsidiaries and divisions to visit the Tranzbyte website at www.tranzbyte.com and sign up to receive our 'Email Alerts' which are sparingly sent to interest-holders periodically. Just click on the orange 'contact' button after arriving at the company's website. Mobile users can also sign up by navigating to the company's website on their android smart phone or iPhone."

Also, shareholder and other interest-holders may track the progress of the pending delivery of our fully automated ZaZZZ™ Machine by following us on Twitter @Tranzbyte or @American__Green (two underscores.)

ABOUT TRANZBYTE

The Tranzbyte Corporation (www.tranzbyte.com) is a driving force behind Altitude Organix, American Green, OneBode, The YO! Debit Card, and BancoLibre. The company expects to continue its plan to acquire, hold, or spin out successful divisions in what has been described in previous news releases as "dividend farming," Companies that qualify and decide to become public on their own will agree to carve out shares for Tranzbyte and dividends for their ERBB shareholders.

Tranzbyte also houses the company's 10-year-old technology division which is actively engaged in the sale of its optical media enhancement products to potential customers in the US and Asia. Products in the Tranzbyte division include FLASHAlbum™ and FlixStix -- technologies that the company plans to be incorporated into the Company's ZaZZZ Machine while enabling distributors of optical media (CDs, DVDs, etc.) to consolidate the best features of each medium onto a single content-protected USB flash drive.

ABOUT ABATTIS BIOCEUTICALS CORP.

Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions by supplying and partnering with companies to employ its vertical cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The company also has an extensive pipeline of high-quality products and Intellectual Property for the rapidly expanding botanical drug market. We follow strict Standard Operating Protocols and adhere to the Law's of Canada and Foreign Jurisdictions. For more information, visit the Company's website at www.abattis.com.